ImClone Investigational Site

Birmingham, Alabama 35294

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Non-Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer — Completed
• A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer — Completed
• A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma — Stopped early